Skip to main content

Government officials will never ask you to transfer money or disclose bank log-in details over a phone call.

Call the 24/7 ScamShield Helpline at 1799 if you are unsure if something is a scam.

Agency for Care Effectiveness
  1. Home
  2. Healthcare professionals
  3. ACE Technology Guidances
  4. Medical Technology Guidances
  5. Minimally invasive glaucoma surgery (MIGS) implants for treating patients with mild to moderate primary open-angle glaucoma (POAG)
Eye

Minimally invasive glaucoma surgery (MIGS) implants for treating patients with mild to moderate primary open-angle glaucoma (POAG)

21 June 2023

Published on 21 Jun 2023
Last Updated on 21 Jun 2023

Guidance Recommendation

The Ministry of Health’s Medical Technology Advisory Committee has recommended subsidy for minimally invasive glaucoma surgery (MIGS) implants, as a standalone intervention or in conjunction with cataract surgery, for the treatment of patients with mild to moderate primary open-angle glaucoma (POAG) who are not adequately responsive to or are intolerant of anti-glaucoma medication.

Funding status

MIGS implants are recommended for inclusion in the Medical Technology Subsidy List (MTSL). Only listed models are recommended for subsidy when used in line with the abovementioned recommendations.

MIGS implants for treating patients with mild to moderate POAG [PDF, 442 KB]

Back to top